RE: Finance5 Aug 2020 15:46
Hi Swinger,
I didn’t see that one ‘issue of equity’. So it actually means that the cash burn has been higher!
They raised.....
5th Feb 2020 CLN £60k for this QPB
13th Jan 2020 £26k from options.
Last QPB, Dec 2018-Dec 2019
1st Oct 2019 £500k issues of equity due to ‘investor demand’
4th Sept £2.75m grant over 5 years to subsidise revenue. (This may help)
6th Aug £275k bookbuild and £20k ish in CLN’s. They asked for 250k got 275k due to ‘investor demand’
Big CLN 29th May 2019...£250k..
“IQ-AI is pleased to announce that the Company has issued £250,000 in nominal amount of 6% unsecured convertible loan notes 2025, convertible into 16,666,666 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.5 pence per share ("CLNs"). The funds raised as a result of the issue of the CLNs will be used to provide additional working capital for product development at the Company.“
Then 11th March 2019..£268k
“Q-AI is pleased to announce that the Company has issued £268,500 in nominal amount of 6% unsecured convertible loan notes 2024, convertible into 13,425,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 2 pence per share ("CLNs"). The funds raised as a result of the issue of the CLNs will be used to provide additional working capital for the Company. The funds raised enables the Company to fully execute its current business plan and shareholders should take comfort that the Company is now able to fully execute its current strategic objectives, following this, initially, non-dilutive fundraise. “
TB has been financing the co through CLN’s. Much of the early cash would have been used for Capex & R&D as well as working capital (wages, fees, travel etc)
If you look at the balance Dec 2019 it’s £865, 875. Admin costs are £859,171. So even without all the other expenses they are evens. Then factor in carry forward loss of £617k, zero tax liabilities (obviously) and allowing for same in revenues there really isn’t much cash left when you take in the spend from Dec 2019 to now.
Like I said revenues will be impacted by covid, significantly plus they still have R&D cost.
Hence my comment is ‘can they freewheel up to the deal or do they raise now on the back of the SP’.
Either way it shouldn’t matter short term as TB has a lot of skin in this. Even though he would get a decent placing price he may not have the cash (I don’t know) but he certainly wouldn’t fancy the dilution. Better to get over the line and let the deal plug the financials.
Any cash/royalty deal will be absolutely transformational for IQAI but imo it’s tight.
Hope that helps clarify.
Trek